返回 A A A Font Size Receive E-mail Alerts Press Releases

MicroPort® Attends MD&M WEST 2018

[2018-03-29] 

Anaheim, US – Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") recently attended the 2018 Medical Design & Manufacturing West ("MD&M WEST") with its subsidiary Shanghai MicroPort D-Pulse Medical Co., Ltd. ("MicroPort® D-Pulse") and Dongguan Kewei Medical Instrument Co., Ltd. ("Dongguan Kewei") to display their products and OEM/ODM samples.
 
MD&M WEST is the world's largest annual expo of medical device and medical device design software, which has been held for 33 years. This year, the medtech event gathered more than 2,200 exhibitors and 20,000 attendees. During the expo, the visitors said they were impressed by the products and the production capacities of MicroPort® and its subsidiaries. General Manager of MicroPort® D-Pulse Dr. Jiahong Tan introduced the surgical accessories to overseas distributors and achieved initial intent of cooperation with the clients from US, Maxico, Brazil, Poland, Iran, South Korea, Japan, and Taiwan. It was the first appearance of MicroPort® D-Pulse in an international congress, which is expected to help promote its technology and products and raise the awareness of its brand. At the same time, Dongguan Kewei displayed its arterial cannula, venous cannula, suction tube, and infusion tube of the extracorporeal circulation machine, as well as the occluders. It attracted attention from several of distributors from US, Mexico, Brazil, and etc. which would help to increase the awareness of the Dongguan Kewei brand and help cultivate the American markets.
 
As a leading medical technology company that develops, manufactures and markets high-end medical devices, MicroPort® not only supplies market-leading products, but also offers OEM and ODM services through its multiple production centers. In the future, MicroPort® will accelerate the implantation of our diversified, global developing strategy to provide patients with more high-quality products.

About MicroPort®

MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 12 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort® is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to: www.microport.com

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words "believe", "intend", "expect", anticipate", "project", "estimate", "predict", "is confident", "has confidence" and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort®'s management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 2018 MicroPort Scientific Corporation

CONTACT:
Amanda Zhang
Corporate Culture & Public Relations Director
Shanghai MicroPort Medical (Group) Co., Ltd. (HQ)
Tel: (86)(21) 38954600-6989
Email: spokesperson@microport.com

 

[Prev]:MicroPort® Single-channel ECG Recorder Becomes the First Product Approved According to the Registration Policy
[Next]:MicroPort® Scientific India Attends Annual Arthroplasty Conference Hyderabad